SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AtheroGenics, Inc.{AGIX}-nasdaq
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Clarksterh who wrote (306)10/21/2007 12:02:16 PM
From: mlrb2113   of 332
 
<<Dr. Fleming is President and Chief Executive Officer of Kinexum LLC, a prominent life sciences consulting firm.

The use of the present tense is odd. Is he not leaving his old job?>>

I didn't notice that, but it strengthens my first impression that AGIX hired him as a consultant (in desperation?) to try to save 1067 from the liver tox issue and possibly other potential problems. I don't think Rob would've left voluntarily or been forced out after all his years there if things looked rosy.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News